(Q44122742)

30 November 2017

title

Topical imiquimod eradicates skin metastases of malignant melanoma but fails to prevent rapid lymphogenous metastatic spread (English)

1 reference

30 November 2017

S Ugurel

1

1 reference

30 November 2017

A Wagner

2

1 reference

30 November 2017

C Pföhler

3

1 reference

30 November 2017

W Tilgen

4

1 reference

30 November 2017

U Reinhold

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

British Journal of Dermatology

30 November 2017

published in

1 reference

30 November 2017

volume

147

1 reference

30 November 2017

issue

3

1 reference

30 November 2017

page(s)

621-624

1 reference

Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.488811.X

Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.488811.X

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.488811.X

Imiquimod 5% cream in the treatment of Bowen's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.488811.X

Imiquimod: a novel treatment for lentigo maligna

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.488811.X

Imiquimod, a topical immune response modifier, induces migration of Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.488811.X

10.1046/J.1365-2133.2002.488811.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference